Updated July 2026 · 10 min read

Serotonin Syndrome vs NMS 2026 — ICU Nurse's Guide

Two patients arrive hyperthermic, altered, and rigid. One got an antipsychotic; the other had an antidepressant dose changed. They can look nearly identical — fever, autonomic instability, muscle abnormalities — but serotonin syndrome and neuroleptic malignant syndrome (NMS) have different triggers, different tempos, different neuromuscular signatures, and partly different treatments. Knowing which one you're looking at changes what you do.

Different mechanisms, similar picture

Serotonin syndrome is a state of too much serotonin activity — usually from combining serotonergic agents or increasing a dose. NMS is essentially the opposite neurotransmitter: too little dopamine activity, from a dopamine antagonist (antipsychotics, some antiemetics like metoclopramide) or from abruptly stopping a Parkinson's dopaminergic drug. They converge on a similar downstream syndrome — hyperthermia, altered mental status, autonomic instability, and neuromuscular abnormality — which is why the history and the neuro exam do most of the differentiating work.

The bedside comparison

What they share — and why it's dangerous

Both can drive severe hyperthermia from sustained muscle activity, and temperatures can climb high enough to cause rhabdomyolysis, acute kidney injury, DIC, and multi-organ failure. Both produce autonomic instability — swinging blood pressure, tachycardia, diaphoresis. The elevated CK, the risk to the kidneys, and the threat of the temperature itself are the same in both, which is why the shared emergency care matters more in the first minutes than nailing the exact diagnosis.

Shared emergency management

Regardless of which it is, the first moves are the same: stop every possible offending drug, cool the patient aggressively, and support the airway, breathing, and circulation. Benzodiazepines are the workhorse for agitation, muscle activity, and autonomic control in both. Aggressive cooling (remove blankets, cooling measures, cold fluids) treats the temperature that's actually doing the organ damage. IV fluids protect the kidneys from myoglobin, and CK, renal function, and coagulation are followed closely.

Where treatment diverges

Beyond the shared care, the specific therapies differ. For serotonin syndrome, the serotonin antagonist cyproheptadine may be used in moderate-to-severe cases. For NMS, options include dantrolene (which reduces muscle rigidity and heat production) and bromocriptine (a dopamine agonist that addresses the underlying dopamine blockade). The severely rigid, hyperthermic patient in either syndrome may need deep sedation, paralysis, and intubation to stop muscle heat production — and if paralyzed, they must be adequately sedated, because paralysis is not sedation.

The nurse's role

You are frequently the person who connects the dots. A patient who becomes agitated, febrile, and jumpy with twitchy, clonic legs hours after a new antidepressant or a tramadol dose is serotonin syndrome until proven otherwise; a patient who becomes progressively rigid, mute, and febrile over days on an antipsychotic is NMS until proven otherwise. Flagging the recent medication change, doing a careful reflex-and-clonus exam, driving early cooling, protecting the kidneys, and watching for the shared complications is where nursing changes the trajectory. Related reading: rhabdomyolysis in the ICU, malignant hyperthermia, and the CIWA/alcohol withdrawal protocol.